Hexarelin treatment in male ghrelin knockout mice after myocardial infarction

Endocrinology

Volumn 154, Issue 10, 2013, Pages 3847-3854

  Mao, Yuanjie ^a   Tokudome, Takeshi ^a   Kishimoto, Ichiro ^a   Otani, Kentaro ^a   Hosoda, Hiroshi ^a   Nagai, Chiaki ^a   Minamino, Naoto ^a   Miyazato, Mikiya ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; HEXARELIN;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIASTOLIC BLOOD PRESSURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART RATE VARIABILITY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TELEMETRY;

ACETYLATION; ANIMALS; CARDIAC OUTPUT; CARDIOTONIC AGENTS; ECHOCARDIOGRAPHY; GHRELIN; HEART; HEART RATE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; OLIGOPEPTIDES; PROTEIN STABILITY; STROKE VOLUME; SURVIVAL ANALYSIS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84884678330     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1291     Document Type: Article

References (41)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660. (Pubitemid 129516334)
2. Bedendi I, Alloatti G, Marcantoni A, et al. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur J Pharmacol. 2003;476:87-95. (Pubitemid 37315540)
3. Baldanzi G, Filigheddu N, Cutrupi S, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol. 2002;159:1029-1037. (Pubitemid 36055757)
4. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87:2988-2991. (Pubitemid 34655375)
5. Nagaya N, Uematsu M, Kojima M, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. 2001;104:1430-1435. (Pubitemid 32880158)
6. Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110:3674-3679. (Pubitemid 39665256)
7. Soeki T, Kishimoto I, Schwenke DO, et al. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol. 2008;294:H426-H432.
8. Schwenke DO, Tokudome T, Kishimoto I, et al. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. Endocrinology. 2008;149:5172-5176.
9. Matsumura K, Tsuchihashi T, Fujii K, Abe I, Iida M. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension. 2002;40:694-699. (Pubitemid 35278606)
10. Lin Y, Matsumura K, Fukuhara M, Kagiyama S, Fujii K, Iida M. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension. 2004;43:977-982. (Pubitemid 38579901)
11. Deghenghi R, Cananzi MM, Torsello A, Battisti C, Muller EE, Locatelli V. GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci. 1994;54:1321-1328. (Pubitemid 24131424)
12. De Gennaro Colonna V, Rossoni G, Bernareggi M, Müller EE, Berti F. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin. Eur J Pharmacol. 1997;334:201-207. (Pubitemid 27451989)
13. Locatelli V, Rossoni G, Schweiger F, et al. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology. 1999;140:4024-4031. (Pubitemid 30647097)
14. Tivesten A, Bollano E, Caidahl K, et al. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology. 2000;141:60-66. (Pubitemid 32266065)
15. Bisi G, Podio V, Valetto MR, et al. Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans. J Endocrinol Invest. 1999;22:266-272. (Pubitemid 29224325)
16. Torsello A, Bresciani E, Rossoni G, et al. Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology. 2003;144:1787-1792. (Pubitemid 36543316)
17. Bodart V, Febbraio M, Demers A, et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res. 2002;90:844-849. (Pubitemid 34633875)
18. Sato T, Kurokawa M, Nakashima Y, et al. Ghrelin deficiency does not influence feeding performance. Regul Pept. 2008;145:7-11. (Pubitemid 350296364)
19. Mao Y, Tokudome T, Otani K, et al. Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves. Endocrinology. 2012;153:3426-3434.
20. Li E, Chung H, Kim Y, et al. Ghrelin directly stimulates adult hippocampal neurogenesis: implications for learning and memory. Endocr J. 2013;60:781-789.
21. Mao Y, Tokudome T, Otani K, Kishimoto I, Miyazato M, Kangawa K. Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice. Endocrinology. 2013;154:1854-1863.
22. Dornonville de la Cour C, Lindqvist A, Egecioglu E, et al. Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice. Gut 2005;54:907-913. (Pubitemid 40873899)
23. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc. 2008;3:1422-1434.
24. Thireau J, Zhang BL, Poisson D, Babuty D. Heart rate variability in mice: a theoretical and practical guide. Exp Physiol. 2008;93:83-94. (Pubitemid 350293971)
25. 2+ channel blockade prevents sudden death in mice with heart failure. Circulation. 2009;120:743-752.
26. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141:122-131.
27. 2+ homeostasis of isolated adult rat ventricular myocytes. Endocrinology. 2010;151:4446-4454.
28. Ma Y, Zhang L, Edwards JN, Launikonis BS, Chen C. Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium. PLoS One. 2012;7:e35265.
29. Ma Y, Zhang L, Launikonis BS, Chen C. Growth hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia/reperfusion heart. Endocrinology. 2012;153:5480-5490.
30. Falls HD, Dayton BD, Fry DG, et al. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C. J Mol Endocrinol. 2006;37:51-62. (Pubitemid 44288605)
31. Kobashi M, Yanagihara M, Fujita M, Mitoh Y, Matsuo R. Fourth ventricular administration of ghrelin induces relaxation of the proximal stomach in the rat. Am J Physiol Regul Integr Comp Physiol. 2009;296:R217-R23.
32. Shimizu S, Akiyama T, Kawada T, et al. Centrally administered ghrelin activates cardiac vagal nerve in anesthetized rabbits. Auton Neurosci. 2011;162:60-65.
33. Kishimoto I, Tokudome T, Schwenke DO, et al. Therapeutic potential of ghrelin in cardiac diseases. Expert Rev Endocrinol Metab. 2009;4:283-289.
34. Bednarek MA, Feighner SD, Pong SS, et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem. 2000;43:4370-4376. (Pubitemid 32046862)
35. Muccioli G, Papotti M, Locatelli V, Ghigo E, Deghenghi R. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest. 2001;24:RC7-RC9. (Pubitemid 32293633)
36. Matsumoto M, Hosoda H, Kitajima Y, et al. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun. 2001;287:142-146. (Pubitemid 32912476)
37. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495-522. (Pubitemid 40404635)
38. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255-4261.
39. Cassoni P, Papotti M, Ghè C, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab. 2001;86:1738-1745. (Pubitemid 32374931)
40. Frascarelli S, Ghelardoni S, Ronca-Testoni S, Zucchi R. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. Basic Res Cardiol. 2003;98:401-405. (Pubitemid 37336627)
41. De Gennaro-Colonna V, Rossoni G, Cocchi D, Rigamonti AE, Berti F, Muller EE. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats. J Endocrinol. 2000;166:529-536.